Boston Scientific stock drops after Stryker denies deal talks
June 14, 2018
Therapeutic Devices | Marlborough, MA
Stryker has announced in an SEC filing that it's not in discussions with Boston Scientific about a possible acquisition. Earlier this week, The Wall Street Journal reported that the medical device makers were mulling a deal that would create a company valued at some $110 billion. Shares of Boston Scientific (NYSE: BSX) fell more than 6% Wednesday.